About Dr. Colvard
David F. Colvard, M.D. is a board-certified psychiatrist (now retired from private practice), clinical investigator, and PADI divemaster who works with anxious and traumatized divers. He learned to dive in 1971 in West Palm Beach, FL, while a Georgia Tech engineering co-op student with Pratt & Whitney Aircraft ,and enjoyed scuba diving there and in the Florida Keys and the Bahamas. The first photo below was taken in 1974 off Palm Beach, FL.
Dr. Colvard received his M.D. from Duke University School of Medicine in Durham, NC, did a year of surgery residency at NC Memorial Hospital in Chapel Hill and three years of psychiatry residency at Duke University Medical Center. It was not until his son was learning to scuba dive that he decided to pursue further dive training and found that he had a knack for working with anxious dive students and traumatized certified divers who wanted to resume diving.
In 2000 Dr. Colvard began conducting paper and online surveys of thousands of divers around the world. His first study on diver panic involved over 12,000 divers. He had a private practice of psychiatry in Raleigh, NC for over 30 years and is now pursuing other activities, like helping new divers become more confident and skilled on Bonaire and elsewhere. He has logged over 1,000 dives in oceans around the world.
“So God created the great creatures of the sea and every living and moving thing with which the water teems… And God saw that it was good.” Genesis 1:21
Financial Disclosures: Dr. Colvard has been a consultant to and representative of NeilMed Pharmaceuticals, the manufacturer of SinusRinse™. He has been on the speaker panels of Bristol-Myers Squibb (BuSpar™ and Serzone™) and other pharmaceutical companies. He has been a clinical investigator or sub-investigator for CIBA-Geigy (Anafranil™ for OCD), Abbott Laboratories (Sertindole™ for schizophrenia), ORGANON USA (Remeron™), GlaxoSmithKline (Lamictal™), NeilMed Pharmaceuticals (SinusRinse™), Astra Zeneca (investigational medication for Generalized Anxiety Disorder), and Pfizer (Varenicline for smoking cessation). He has been a psychiatric consultant to Wake Research Associates for Boehringer Ingelhein (flibanserin) and other IND trials.